Search Results - "Beveridge, R. Díaz"

Clinical guideline SEOM: hepatocellular carcinoma by Sastre, J., Díaz-Beveridge, R., García-Foncillas, J., Guardeño, R., López, C., Pazo, R., Rodriguez-Salas, N., Salgado, M., Salud, A., Feliu, J.

“…Hepatocellular carcinoma (HCC) represents the second leading cause of cancer-related death worldwide. Surveillance with abdominal ultrasound every 6 months…”
Get full text

Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS) by Martin-Broto, J., Redondo, A., Valverde, C., Vaz, M.A., Mora, J., Garcia del Muro, X., Gutierrez, A., Tous, C., Carnero, A., Marcilla, D., Carranza, A., Sancho, P., Martinez-Trufero, J., Diaz-Beveridge, R., Cruz, J., Encinas, V., Taron, M., Moura, D.S., Luna, P., Hindi, N., Lopez-Pousa, A.

“…Patients with relapsed unresectable osteosarcoma represents an unmet need, so active and safe systemic treatments are required. Fas cell surface death receptor…”
Get full text

Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients by de Toro Carmena, M., Ortega Morán, L., García Adrián, S., Castañón López, C., Molina Villaverde, R., Marrupe González, D., Lopez Muñoz, A., Alcaraz Nunes, D., Díaz Beveridge, R., López Alfonso, A., García Paredes, B., Fernández Montes, A., Soriano Rodríguez, M., Encinas García, S., Alcaide García, J., Pericay Pijaume, C., Macarulla Mercadé, T., Rodríguez-Salas, N., García Alfonso, P., Muñoz Martín, A.

Get full text

SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016) by Martin-Richard, M., Díaz Beveridge, R., Arrazubi, V., Alsina, M., Galan Guzmán, M., Custodio, A. B., Gómez, C., Muñoz, F. L., Pazo, R., Rivera, F.

“…Esophageal cancer (EC) is an aggressive tumor that represents the 6th most common cause of cancer death worldwide. The estimated incidence in Spain is 2090…”
Get full text

2250 Phase II trial of neoadjuvant gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy in resectable pancreatic adenocarcinoma. A GEMCAD 10–03 trial by Laquente, B, Conill, C, Fabregat, J, Cambray, M, Ayuso, J.R, Valls, C, Bombí, J.A, Serrano, T, Ferrández, A, Povés, I, Sabater, L, Montagut, C, Roselló, S, Martín-Richard, M, Díaz-Beveridge, R, Rodriguez, J, Gallego, R, García-Alb éniz, X, Fernández-Cruz, L, Maurel, J

Get full text

Clinical guideline SEOM: hepatocellular carcinoma by Sastre, J., Díaz-Beveridge, R., García-Foncillas, J., Guardeño, R., López, C., Pazo, R., Rodriguez-Salas, N., Salgado, M., Salud, A., Feliu, J.

Get full text

P.16 Social support of elderly lung cancer patients by Gironés, R, Díaz-Beveridge, R, Torregrosa, D, López, P, Gómez-Codina, J, Yuste, A, Saldaña, J, Rosell, R

Get full text

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables by Ponce Lorenzo, J, Segura Huerta, A, Díaz Beveridge, R, Giménez Ortiz, A, Aparisi Aparisi, F, Fleitas Kanonnikoff, T, Richart Aznar, P, de la Cueva Sapiña, H, Montalar Salcedo, J

“…To identify clinical and biologic variables with significant impact on survival in patients with carcinomas of an unknown primary site (CUP) and to develop a…”
Get full text

An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib by Diaz-Beveridge, R., Bruixola, G., Lorente, D., Caballero, J., Rodrigo, E., Segura, Á., Akhoundova, D., Giménez, A., Aparicio, J.

“…Background Sorafenib is a standard treatment for patients (pts) with advanced hepatocellular carcinoma (aHCC), although the clinical benefit is heterogeneous…”
Get full text

P-182 Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer by Gallego, R. Álvarez, Cid, R. Pazo, López de San Vicente, B., Macarulla, T., Martinez de Castro, E., Goldaraz, F. Garicano, Granja, M., Ghanem, I., Martinez-Galán, J., Fernández, P. Ribera, Beveridge, R. Díaz, Valadés, J. Martín, Ángeles, C., Cubillo, A.

Get full text

2134 Comparative analysis of the Kohne, GERCOR and GEMCAD prognostic models in metastatic colorectal cancer (mCRC) patients treated with first-line bevacizumab-based combination chemotherapy by Bruixola, G, Diaz-Beveridge, R, Melian, M, Caballero, J, Nino, O, Escoin, C, Akhoundova, D, Salvador, C, Segura, A, Gimenez, A, Aparicio, J

Get full text

2288 Validation of the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram after surgery for localized pancreatic adenocarcinoma: Long-term results from a Spanish pancreatic cancer surgery reference centre by Salvador, C, Diaz Beveridge, R, Niño, O.M, Moya, A, Hervas, D, Akhoundova, D, López-Andújar, R, Bruixola, G, Segura, A, Escoin, C, Reche, E, Montalva, E, Aparicio, J

Get full text

2326 An internally validated new clinical prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib by Bruixola, G, Diaz Beveridge, R, Niño, O.M, Reche, E, Salvador, C, Escoin, C, Akhoundova, D, Segura, A, Gimenez, A, Aparicio, J

Get full text

2325 A study of the representativity of the NCIC, PRODIGE and MPACT phase III trials of gemcitabine-erlotinib, FOLFIRINOX and gemcitabine-nab-paclitaxel in patients with advanced pancreatic cancer treated in a real-life setting by Aknoundova, D, Diaz Beveridge, R, Escoin, C, Segura, A, Bruixola, G, Reche, E, Gimenez, A, Salvador, C, Niño, O.M, Aparicio, J

Get full text

1932P First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma by González, J.A., Sebio, A., Beveridge, R. Díaz, Castellanos, J.F. Orbis, Andújar, R. López, Álvarez, R. Álvarez, Asencio, J. Manuel, Martin-Broto, J., Hindi, N., Jimenez, M., Villarejo-Campos, P., García, C. Serrano, Rodríguez, N., Boix, S. Castro, Campos, A. Perez, Casas, F. Cano, García, J.A. Tornero, Marti, L., Krauel, L., Pousa, A. Lopez

Get full text

1114P Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002 - BECARE) by Soria, A., Sanchez Mauriño, P., García Galindo, R., Sequero, S., Gutiérrez Sanz, L., Crespo, G., Díaz-Beveridge, R., Puértolas, T., López, P., Fra Rodríguez, J., López Castro, R., Aguayo, C., Valdivia, J., Cunquero-Tomás, A., Benítez, G., Ayala de Miguel, P., Espinosa, E., Muñoz-Couselo, E., Campos, B., Cerezuela-Fuentes, P.

Get full text

PO-1557 RT after Encorafenib and Binimetinib on BRAF mutated melanoma brain metastases. GEM1802-Phase II by Alvarez, A., Valduvieco, I., Arance, A., Delgado, R., Berciano, M.A., López Campos, F., Soria, A., Romero, J.L., Sánchez Mauriño, P., Lucas, A., Martín Liberal, J., Prada, P.J., García Castaño, A., Alamo, M.C., Puertas, E., González Cao, M., Conde, A., Díaz Beveridge, R., Corona, J.A., Aguado, C., Foro, P., Vidal, J., López Soler, F., Cerezuela Fuentes, P., Márquez Rodas, I.

Get full text

837P Real-world evidence of encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma in Spain (GEM 2002 - BECARE) by Soria, A., Sánchez Mauriño, P., Serrano, J.J., Sequero, S., Fra Rodríguez, J., Amezcua, V., Benítez, G., Espinosa, E., Aguayo, C., García Galindo, R., Díaz-Beveridge, R., Puértolas, T., Cunquero-Tomás, A., López Castro, R., Crespo, G., López, P., Gutiérrez Sanz, L., Campos, B., García, L., Cerezuela-Fuentes, P.

Get full text

1038MO Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial by Marquez-Rodas, I., Arance, A., Berciano Guerrero, M.A., Díaz Beveridge, R., Alamo, M.D.C., Garcia Castaño, A., Gonzalez Cao, M., Vidal, J., Puertolas Hernandez, T., Soria, A., Aguado de la Rosa, C., Sánchez Mauriño, P., Valduvieco, I., Delgado Rico, R., Conde, A., Foro, P., Prada, P.J., Puertas, E., Alvarez Gonzalez, A., Berrocal, A.

Get full text

P-190Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients by de Toro Carmena, M, Ortega Morán, L, García Adrián, S, Castañón López, C, Molina Villaverde, R, Marrupe González, D, Lopez Muñoz, A, Alcaraz Nunes, D, Díaz Beveridge, R, López Alfonso, A, García Paredes, B, Fernández Montes, A, Soriano Rodríguez, M, Encinas García, S, Alcaide García, J, Pericay Pijaume, C, Macarulla Mercadé, T, Rodríguez-Salas, N, García Alfonso, P, Muñoz Martín, A

Get full text